Bird Flu
New vaccine against deadliest strain of avian flu tested by University of Pittsburgh scientists
Published in Gene Therapy Weekly, February 14th, 2008
A vaccine against the most common and deadliest strain of avian flu, H5N1, has been engineered and tested by researchers at the University of Pittsburgh’s Center for Vaccine Research and Novavax Inc. According to a study published by the Public Library of Science in the Jan. 30 issue of PLoS ONE, the vaccine produced a strong immune response in mice and protected them from death following infection with the H5N1 virus. The vaccine is being tested in humans in an early-phase clinical trial.
Recent outbreaks of avian flu around the world have prompted health officials to warn of its continued threat to global health and potential to trigger a flu pandemic. "While...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2008-02-14)
More Articles from Gene Therapy Weekly
- Testicular Cancer
2 microRNAs promote spread of tumor cells - Angiogenesis
New angiogenesis study findings have been reported by researchers at Wayne State University - Angiogenesis
Study data from University of Freiburg provide new insights into angiogenesis - Apoptosis
New apoptosis research from J. Li et al outlined - Breast Cancer
Findings in breast cancer reported from Thomas Jefferson University - Breast Cancer
Medical University of Vienna reports research in breast cancer - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
